Phase 2 ADHD trials recruiting now

All ADHD trials, every phase

Other phases for ADHD

Phase 2 ADHD trials

• A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
  NCT07755410 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
  NCT07086313 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 1 location
• Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)
  NCT07592390 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 1 location
• Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression
  NCT06967857 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
  NCT05608434 · Phase: Phase 1, Phase 2 · Ages: 8 Years to 16 Years · Sex: All (male and female) · 1 location
• Dual-target iTBS for Youth With ADHD
  NCT07084649 · Phase: Phase 1, Phase 2 · Ages: 10 Years to 18 Years · Sex: All (male and female) · 1 location
• Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
  NCT05133804 · Phase: Phase 2 · Ages: 20 Years to 60 Years · Sex: All (male and female) · 3 locations
• Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
  NCT06931080 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
  NCT05957055 · Phase: Phase 2 · Ages: 8 Years to 198 Months · Sex: All (male and female) · 1 location
• Pathways 2 Success
  NCT06831123 · Phase: Phase 1, Phase 2 · Ages: 13 Years to 17 Years · Sex: All (male and female) · 1 location
• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
  NCT06081348 · Phase: Phase 2 · Ages: 8 Years to 17 Years · Sex: All (male and female) · 7 locations
• The Effects of Cannabigerol on Attention-Deficit/Hyperactivity Disorder
  NCT06115603 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 1 location
• The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
  NCT06542445 · Phase: Phase 2 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.